Norris Perne & French LLP MI lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 2.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,619 shares of the medical research company’s stock after […]